KalVista Pharmaceuticals - 53 Year Dividend History | KALV
Historical dividend payout and yield for KalVista Pharmaceuticals (KALV) since 1971. The current TTM dividend payout for KalVista Pharmaceuticals (KALV) as of November 20, 2024 is $0.00. The current dividend yield for KalVista Pharmaceuticals as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.391B |
$0.000B |
|
KalVista Pharmaceuticals, Inc. is a pharmaceuticals company. It engages in discovery, development and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product portfolio consist hereditary angioedema and diabetic macular edema, KVD818 and KVD001, which are in clinical stage. KalVista Pharmaceuticals, Inc., formerly known as Carbylan Therapeutics, Inc., is headquartered in Cambridge, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
